The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for T Ullrich


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administration.EBI
Novartis Institutes For Biomedical Research
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: variation of the delta address and its effects on affinity and selectivity for the delta opioid receptor.EBI
Niddk
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva.EBI
Novartis Institutes For Biomedical Research
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.EBI
Novartis Institutes For Biomedical Research
Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor.EBI
Vienna University of Technology
Human plasma kallikrein inhibitorsBDB
Biocryst Pharmaceuticals
MAP kinase modulators and uses thereofBDB
Columbia University
SHMT inhibitorsBDB
The Trustees of Princeton University
FXR (NR1H4) modulating compoundsBDB
Gilead Sciences
Antidiabetic bicyclic compoundsBDB
Merch Sharp & Dohne Corp. Rahway
Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.BDB
Argonne National Laboratory